(19)
(11) EP 4 747 279 A1

(12)

(43) Date of publication:
27.05.2026 Bulletin 2026/22

(21) Application number: 24748837.2

(22) Date of filing: 16.07.2024
(51) International Patent Classification (IPC): 
C07K 16/22(2006.01)
A61P 35/00(2006.01)
A61K 39/395(2006.01)
A61P 37/04(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/22; C07K 2317/76; A61K 2039/505; A61P 35/00; A61P 37/04
(86) International application number:
PCT/EP2024/070099
(87) International publication number:
WO 2025/017003 (23.01.2025 Gazette 2025/04)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 18.07.2023 IT 202300015063

(71) Applicant: Andremacon S.r.l.
20139 Milano (IT)

(72) Inventors:
  • MARFIA, Giovanni
    20138 Milan (IT)
  • NAVONE, Stefania Elena
    20147 Milan (IT)
  • CAMPANELLA, Rolando
    29029 Rivergaro (IT)
  • SCALVINI, Giuseppe
    25024 Castelletto di Leno (IT)
  • BARILLA, Emanuela
    43126 Parma (IT)
  • ALOTTA, Giovanni Andrea
    90030 Altofonte (IT)

(74) Representative: Zaccaro, Elisabetta et al
Notarbartolo & Gervasi S.p.A. Viale Achille Papa, 30
20149 Milano
20149 Milano (IT)

   


(54) METHOD FOR BOOSTING THE EFFICACY OF IMMUNOTHERAPY AND ENHANCING THE HOST IMMUNE RESPONSE